BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo W, Olaru F, Miner JH, Beck LH Jr, van der Vlag J, Thurman JM, Borza DB. Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. Front Immunol 2018;9:1433. [PMID: 29988342 DOI: 10.3389/fimmu.2018.01433] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Saleem M, Shaikh S, Hu Z, Pozzi N, Java A. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature. Front Immunol 2022;13:909503. [PMID: 35720299 DOI: 10.3389/fimmu.2022.909503] [Reference Citation Analysis]
2 Brglez V, Boyer-Suavet S, Seitz-Polski B. Complement Pathways in Membranous Nephropathy: Complex and Multifactorial. Kidney Int Rep 2020;5:572-4. [PMID: 32406418 DOI: 10.1016/j.ekir.2020.02.1033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Dong Z, Liu Z, Dai H, Liu W, Feng Z, Zhao Q, Gao Y, Liu F, Zhang N, Dong X, Zhou X, Du J, Huang G, Tian X, Liu B. The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy. J Immunol Res 2020;2020:7638365. [PMID: 33426094 DOI: 10.1155/2020/7638365] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Fakhouri F, Schwotzer N, Golshayan D, Frémeaux-bacchi V. The rational use of complement inhibitors in kidney diseases. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.02.021] [Reference Citation Analysis]
5 Bhatia D, Choi ME. Autophagy in kidney disease: Advances and therapeutic potential. Prog Mol Biol Transl Sci 2020;172:107-33. [PMID: 32620239 DOI: 10.1016/bs.pmbts.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Zhang Y, Jin Y, Guan Z, Li H, Su Z, Xie C, Chen X, Liu X, Pan Y, Ye P, Zhang L, Kong Y, Luo W. The Landscape and Prognosis Potential of the T-Cell Repertoire in Membranous Nephropathy. Front Immunol 2020;11:387. [PMID: 32210970 DOI: 10.3389/fimmu.2020.00387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Dong Z, Dai H, Gao Y, Feng Z, Liu W, Liu F, Zhang Z, Ma F, Xie X, Zhu Z, Liu W, Liu B. Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes. Exp Ther Med 2021;22:737. [PMID: 34055054 DOI: 10.3892/etm.2021.10169] [Reference Citation Analysis]
8 Genest DS, Bonnefoy A, Khalili M, Merlen C, Genest G, Lapeyraque A, Patey N, Smail N, Royal V, Troyanov S. Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 van de Logt AE, Fresquet M, Wetzels JF, Brenchley P. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 2019;96:1292-1302. [PMID: 31611068 DOI: 10.1016/j.kint.2019.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
10 Jiang HX, Feng Z, Zhu ZB, Xia CH, Zhang W, Guo J, Liu BL, Wang Y, Liu YN, Liu WJ. Advances of the experimental models of idiopathic membranous nephropathy (Review). Mol Med Rep 2020;21:1993-2005. [PMID: 32186751 DOI: 10.3892/mmr.2020.11014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Stahl RA, Reinhard L, Hoxha E. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance. Expert Rev Clin Immunol 2019;15:165-75. [PMID: 30433832 DOI: 10.1080/1744666X.2019.1548934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Koneczny I. Update on IgG4-mediated autoimmune diseases: New insights and new family members. Autoimmun Rev 2020;19:102646. [PMID: 32801046 DOI: 10.1016/j.autrev.2020.102646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
13 Liu W, Gao C, Dai H, Zheng Y, Dong Z, Gao Y, Liu F, Zhang Z, Liu Z, Liu W, Liu B, Liu Q, Shi J. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role. Front Immunol 2019;10:1809. [PMID: 31447839 DOI: 10.3389/fimmu.2019.01809] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
14 Lateb M, Ouahmi H, Payré C, Brglez V, Zorzi K, Dolla G, Zaidan M, Boyer-Suavet S, Knebelmann B, Crépin T, Courivaud C, Jourde-Chiche N, Esnault V, Lambeau G, Seitz-Polski B. Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation. J Immunol Res 2019;2019:1324804. [PMID: 32083137 DOI: 10.1155/2019/1324804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
15 Schubart A, Anderson K, Mainolfi N, Sellner H, Ehara T, Adams CM, Mac Sweeney A, Liao SM, Crowley M, Littlewood-Evans A, Sarret S, Wieczorek G, Perrot L, Dubost V, Flandre T, Zhang Y, Smith RJH, Risitano AM, Karki RG, Zhang C, Valeur E, Sirockin F, Gerhartz B, Erbel P, Hughes N, Smith TM, Cumin F, Argikar UA, Haraldsson B, Mogi M, Sedrani R, Wiesmann C, Jaffee B, Maibaum J, Flohr S, Harrison R, Eder J. Small-molecule factor B inhibitor for the treatment of complement-mediated diseases. Proc Natl Acad Sci U S A 2019;116:7926-31. [PMID: 30926668 DOI: 10.1073/pnas.1820892116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
16 Lin DW, Chang CC, Hsu YC, Lin CL. New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid. Int J Mol Sci 2022;23:3525. [PMID: 35408886 DOI: 10.3390/ijms23073525] [Reference Citation Analysis]
17 Lu H, Luo Y, Su B, Tang S, Chen G, Zhang L, Song C, Wang C, Tu H, Wu X. Wenyang Lishui Decoction Ameliorates Podocyte Injury in Membranous Nephropathy Rat and Cell Models by Regulating p53 and Bcl-2. Evid Based Complement Alternat Med 2020;2020:6813760. [PMID: 32454867 DOI: 10.1155/2020/6813760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Ahmadi A, Moghadasali R, Ezzatizadeh V, Taghizadeh Z, Nassiri SM, Asghari-Vostikolaee MH, Alikhani M, Hadi F, Rahbarghazi R, Yazdi RS, Baharvand H, Aghdami N. Transplantation of Mouse Induced Pluripotent Stem Cell-Derived Podocytes in a Mouse Model of Membranous Nephropathy Attenuates Proteinuria. Sci Rep 2019;9:15467. [PMID: 31664077 DOI: 10.1038/s41598-019-51770-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
19 Struk T, Nair V, Eichinger F, Kretzler M, Wedlich-Söldner R, Bayraktar S, Pavenstädt H. Transcriptome analysis of primary podocytes reveals novel calcium regulated regulatory networks. FASEB J 2020;34:14490-506. [PMID: 32931033 DOI: 10.1096/fj.201902493RR] [Reference Citation Analysis]
20 Gu Y, Xu H, Tang D. Mechanisms of Primary Membranous Nephropathy. Biomolecules 2021;11:513. [PMID: 33808418 DOI: 10.3390/biom11040513] [Reference Citation Analysis]
21 Zhang J, Zhu Y, Cai R, Jin J, He Q. Differential Expression of Urinary Exosomal Small RNAs in Idiopathic Membranous Nephropathy. Biomed Res Int 2020;2020:3170927. [PMID: 33457405 DOI: 10.1155/2020/3170927] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Reinhard L, Stahl RAK, Hoxha E. Is primary membranous nephropathy a complement mediated disease? Mol Immunol 2020;128:195-204. [PMID: 33142137 DOI: 10.1016/j.molimm.2020.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]